Both in Pharmaceuticals
Geron vs Design Therapeutics
Over the past year GERN returned −5.3% and DSGN returned +84.2%; their daily moves had a correlation of 0.28.
GERN −5.3% DSGN +84.2%Growth of $1, one year, split-adjusted
| Metric | GERN | DSGN |
|---|---|---|
| Price | $1.24 | $12.62 |
| Market cap | $796.7M | $789.8M |
| Today | −0.80% | +2.10% |
| 1 month | −17.9% | −16.5% |
| 6 months | −12.1% | +21.7% |
| Year to date | −6.1% | +34.5% |
| 1 year | −3.9% | +92.1% |
| Revenue growth (YoY) | +17.2% | — |
| Gross margin | 83.9% | — |
| Net margin | −29.0% | — |
| P/E (TTM) | — | — |
| Price / sales | 3.9× | — |
| Net cash | $51.1M | $207.4M |
| Dividend yield | — | — |
| Volatility (60d) | 66.5% | 52.6% |
| Short % of float | 13.2% | 21.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).